127 related articles for article (PubMed ID: 15964372)
1. Treatment of steroid-resistant acute liver transplant rejection with basiliximab.
Fernandes ML; Lee YM; Sutedja D; Wai CT; Isacc J; Prabhakaran K; Lim SG; Lee KH
Transplant Proc; 2005 Jun; 37(5):2179-80. PubMed ID: 15964372
[TBL] [Abstract][Full Text] [Related]
2. Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation.
Orr DW; Portmann BC; Knisely AS; Stoll S; Rela M; Muiesan P; Bowles MJ; Heaton ND; O'Grady JG; Heneghan MA
Transplant Proc; 2005 Dec; 37(10):4373-9. PubMed ID: 16387124
[TBL] [Abstract][Full Text] [Related]
3. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D
Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588
[TBL] [Abstract][Full Text] [Related]
4. [Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation].
Alvarez Castro AM; Seijo Ríos S; Molina Pérez E; Castroagudín JF; Varo Pérez E
Gastroenterol Hepatol; 2012 Nov; 35(9):649-51. PubMed ID: 22749511
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients.
Ganschow R; Grabhorn E; Schulz A; Von Hugo A; Rogiers X; Burdelski M
Pediatr Transplant; 2005 Dec; 9(6):741-5. PubMed ID: 16269045
[TBL] [Abstract][Full Text] [Related]
6. A safe immunosuppressive protocol in adult-to-adult living related liver transplantation.
Gruttadauria S; Cintorino D; Piazza T; Mandala L; Doffria E; Musumeci A; Di Trapani G; Arcadipane A; Scianna G; Spada M; Verzaro R; Volpes R; Vizzini G; Palazzo U; Minervini M; Marsh JW; Marcos A; Gridelli B
Transplant Proc; 2006 May; 38(4):1106-8. PubMed ID: 16757278
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J
Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466
[TBL] [Abstract][Full Text] [Related]
8. Basiliximab as therapy for acute rejection after liver transplantation for hepatitis C virus cirrhosis.
Togashi J; Sugawara Y; Tamura S; Kaneko J; Yamashiki N; Aoki T; Hasegawa K; Kokudo N
Biosci Trends; 2011; 5(2):57-60. PubMed ID: 21572248
[TBL] [Abstract][Full Text] [Related]
9. Basiliximab treatment for steroid-resistant rejection in pediatric patients following liver transplantation for acute liver failure.
Shigeta T; Sakamoto S; Uchida H; Sasaki K; Hamano I; Kanazawa H; Fukuda A; Kawai T; Onodera M; Nakazawa A; Kasahara M
Pediatr Transplant; 2014 Dec; 18(8):860-7. PubMed ID: 25311536
[TBL] [Abstract][Full Text] [Related]
10. Steroid-free liver transplantation in children.
Reding R; Gras J; Sokal E; Otte JB; Davies HF
Lancet; 2003 Dec; 362(9401):2068-70. PubMed ID: 14697809
[TBL] [Abstract][Full Text] [Related]
11. Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience.
Aw MM; Taylor RM; Verma A; Parke A; Baker AJ; Hadzic D; Muiesan P; Rela M; Heaton ND; Mieli-Vergani G; Dhawan A
Transplantation; 2003 Mar; 75(6):796-9. PubMed ID: 12660504
[TBL] [Abstract][Full Text] [Related]
12. Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation.
Gruttadauria S; Vasta F; Mandalà L; Cintorino D; Piazza T; Spada M; Verzaro R; Gridelli B
Transplant Proc; 2005; 37(6):2611-3. PubMed ID: 16182762
[TBL] [Abstract][Full Text] [Related]
13. Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids.
Asensio M; Margarit C; Chavez R; Ortega J; Charco R; Iglesias J
Transplant Proc; 2002 Aug; 34(5):1970-1. PubMed ID: 12176650
[No Abstract] [Full Text] [Related]
14. Basiliximab-chimeric anti-IL2-R monoclonal antibody in pediatric liver transplantation: comparative study.
Gibelli NE; Pinho-Apezzato ML; Miyatani HT; Maksoud-Filho JG; Silva MM; Ayoub AA; Santos MM; Velhote MC; Tannuri U; Maksoud JG
Transplant Proc; 2004 May; 36(4):956-7. PubMed ID: 15194332
[TBL] [Abstract][Full Text] [Related]
15. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial.
Neuhaus P; Clavien PA; Kittur D; Salizzoni M; Rimola A; Abeywickrama K; Ortmann E; Chodoff L; Hall M; Korn A; Nashan B;
Liver Transpl; 2002 Feb; 8(2):132-42. PubMed ID: 11862589
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid.
Teraoka S; Sato S; Sekijima M; Iwado K; Urashima Y; Kudo S; Kai K; Koyama I; Tojinbara T; Nakajima I; Fuchinoue S
Transplant Proc; 2005 Mar; 37(2):791-4. PubMed ID: 15848533
[TBL] [Abstract][Full Text] [Related]
17. Basiliximab induction in adult liver transplant recipients with 93% rejection-free patient and graft survival at 24 months.
Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
Transplant Proc; 2006 Dec; 38(10):3633-5. PubMed ID: 17175352
[TBL] [Abstract][Full Text] [Related]
18. Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children.
Gras JM; Gerkens S; Beguin C; Janssen M; Smets F; Otte JB; Sokal E; Reding R
Liver Transpl; 2008 Apr; 14(4):469-77. PubMed ID: 18383091
[TBL] [Abstract][Full Text] [Related]
19. Basiliximab in the therapy of acute rejection after organ transplantation.
Chariat MN; Erren M; Chariat M; Deng M; Wolters HH; Dietl KH
Transplant Proc; 2001 May; 33(3):2380. PubMed ID: 11377567
[No Abstract] [Full Text] [Related]
20. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G
Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
